However, depending on the tumoural or therapeutic context, TAMs are also capable of exerting anti-tumorigenic pressures, either autonomously or by fostering the effector/cytotoxic activity of CD8+T cells [3]. The gene discussed is CD8A; the disease is neoplasm.